BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 17, 2004
View Archived Issues
Antitumor effects of CpG-7909 in several types of human cancer
Read More
Synthetic Australian snake venom derivative effective for wound healing
Read More
Restoration of CFTR function with SV40 gene therapy
Read More
Antitumor effects and safety of rhLF in advanced cancer patients
Read More
Novel potent and selective 5-HT2C agonists for the treatment of obesity discovered at Wyeth
Read More
Study results on GLP-1 analogue CJC-1131 presented during ADA
Read More
Synergistic effects of IL-21 and rituximab in B-lymphoma cell lines
Read More
An EGF vaccine reported to improve survival in advanced lung cancer
Read More
Positive preliminary phase III results for Sativex in neuropathic pain
Read More
Crucell enters PER.C6 licensing agreement with Chiron
Read More
FDA accepts IND for stem cell mobilizing drug CTCE-0214
Read More
Sosei's phase I trial of SOU-001 cleared to begin in U.K.
Read More
First patient enrolled in phase I/II study of TheraCIM hR3 for pediatric glioma
Read More
ZYC-101a shows 100% efficacy in patients with high-grade cervical dysplasia
Read More
Pivotal phase III trial of Rencarex for renal cell carcinoma opens enrollment
Read More
Symadex enters phase I in patients with advanced solid tumors
Read More
SVT-40776 progresses into phase II for urinary incontinence
Read More
Daily Infergen plus ribavirin evaluated for HCV in new DIRECT trial
Read More
Ovation acquires Buronil from Lundbeck
Read More
IR-103 enters first clinical study for HIV
Read More
First phase IIa patients receive BrachySil for liver cancer
Read More
Two series of gamma-secretase inhibitors identified at Merck
Read More
AstraZeneca presents novel PTP-1B inhibitors
Read More
Boehringer Ingelheim scientists describe new ICAM-1/LFA-1 interaction inhibitors
Read More
Dual alpha7 nAChR agonists/5-HT3 antagonists for psychosis, cognition disorders, etc.
Read More
New antilipolytic agents targeting hRUP38 receptors
Read More
T-614 reported safe and effective in patients with active rheumatoid arthritis
Read More
Novel chemokine CCR1 antagonists and their use covered by Pfizer patent
Read More
New monoamine reuptake inhibitors developed at NeuroSearch
Read More
Preliminary data on the efficacy of epratuzumab in SLE
Read More
Clinical response found with eculizumab in rheumatoid arthritis
Read More